Author

MF Drummond

Observed names: Drummond, M, Drummond, MF, M Drummond, M. Drummond, M. F. Drummond, M.F. Drummond

OpenAlex ID: A5067085896

Pes6 Cost Effectiveness of Photodynamic Therapy (pdt) With Verteporfin in the Uk

2002 · DH Smith, P Fenn, et al. · Value in Health · 3

PDF

Pcn162 Extrapolation in Trial-based Cost-effectiveness Modeling: in Search of a Standard

2010 · M Ekman, C Charbonneau, et al. · Value in Health · 2

Assessment and Appraisal of Oncology Medicines: NICE's Approach and International HTA Experience

2009 · Martina Garau, Koonal Shah, et al. · RePEc: Research Papers in Economics · 1

Hp2 Nhs Reimbursement of New Cancer Drugs: Is Nice Getting Nastier?

2008 · AR Mason, MF Drummond · Value in Health · 1

PDF

Php32 Obtaining Value for Money From Pharmaceuticals: Reference Pricing or Health Technology Assessment?

2007 · MF Drummond, B Jonsson, et al. · Value in Health · 1

Po16-439 Cost-effectiveness of Intensive Lipid-lowering Treatment in Secondary Cardiovascular Prevention in Spain and Germany

2007 · D.C.A. Taylor, A. Pandya, et al. · Atherosclerosis Supplements · 1

Mo-P5:344 Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80MG versus 10MG in secondary cardiovascular prevention in the UK

2006 · D.C.A. Taylor, A. Pandya, et al. · Atherosclerosis Supplements · 1

Php4 Are the Results of Economic Evaluations Generalizable? Evidence From Studies of Pharmaceuticals in Western Europe

2003 · M Barbieri, MF Drummond, et al. · Value in Health · 1

PDF

Php34: Improving Outcomes Through Access to Critiqued Economic Evaluations:the Nhs Economic Evaluation Database Within the Hta Review Process

2003 · J Nixon, SB Duffy, et al. · Value in Health · 1

PDF

Pao8: the Cost-effectiveness of Infliximab for Severe Rheumatoid Arthritis

2001 · M Barbieri, JB Wong, et al. · Value in Health · 1

Economics in cancer care

1995 · M.F. Drummond · European Journal of Cancer · 1

Ee3 Is Nice Too Nasty? a Comparison of Anticancer Drug Coverage Decisions in the United States and Uk

2009 · AR Mason, MF Drummond, et al. · Value in Health

Co3 Estimating Drug Costs in Economic Evaluations in Ireland and the Uk: an Analysis of Practice and Research Recommendations

2009 · DA Hughes, L Tilson, et al. · Value in Health

Php17 Recommendations From Reimbursement Agencies Foradditional Post-launch Research. the Next Hurdle

2007 · D Marshall, HE Yong, et al. · Value in Health

PDF

NHS Economic Evaluation Database Handbook. Chapter III: Guidance for writing NHS EED abstracts.

2007 · Craig, D, Rice, S, et al. · LSHTM Research Online (London School of Hygiene and Tropical Medicine)

Cv3 Cost-effectivenesss of Intensive Statin Therapy Compared to Moderate Statin Therapy in Patients With Acute Coronary Syndrome: Analysis From Canada, Germany and the Uk

2006 · MF Drummond, JS Schwartz, et al. · Value in Health

PDF

Pcv28 Cost-effectiveness of Intensive Lipid-lowering Treatment in Secondary Cardiovascular Prevention in Spain and Germany

2006 · DC Taylor, A Pandya, et al. · Value in Health

Pmc11 Development of a Global Health Economic Model of the Natural History of Hpv Infection and Cervical Cancer: Calibration to the United Kingdom and Netherlands

2006 · N Ferko, MA Kohli, et al. · Value in Health

PDF

Estimating the long-term impact of a prophylactic human papillomavirus (HPV) 16/18 vaccine on the burden of cervical disease in the UK

2006 · Kohli, M, Ferko, N, et al. · UCL Discovery (University College London)

Pih4 What Methods of Assessment and Management of Elderly People Are Cost Effective

2005 · LM Davies, M Drummond · Value in Health

PDF

Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults :

2005 · Neil Hawkins, David H. Epstein, et al. · LSHTM Research Online (London School of Hygiene and Tropical Medicine)

Pmc4 Can Economic Evaluations Be Made More Transferable?

2004 · MF Drummond, SM Boulenger, et al. · Value in Health

PDF

Phpi8 Introducing the ‘fourth Hurdle’ in the New European Union Member States: the Case of Hungary

2004 · L Gulácsi, I Boncz, et al. · Value in Health

PDF

Pmc5 Are the Best Available, Most Applicable Clinical Effectiveness Data Used in Economic Evaluations of Drug Therapies?

2004 · MF Drummond, B Hanratty, et al. · Value in Health

PDF

Csi Tegaserod Is Cost-effective in the Treatment of Patients With Ibs: an Economic Analysis of the Tenor (tegaserod in Nordic Countries) Study

2004 · B Jönsson, A Braceo, et al. · Value in Health

PDF

Works count: 37

Citation count: 14

H-index: 2

I10-index: